Geron ( NASDAQ:GERN – Get Free Report ) posted its quarterly earnings data on Thursday. The biopharmaceutical company reported ($0.09) EPS for the quarter, missing the consensus estimate of ($0.08) by ($0.01), reports. Geron had a negative net margin of 38,007.78% and a negative return on equity of 99.78%. The company had revenue of $0.03 million for the quarter, compared to analysts' expectations of $0.14 million. Geron Stock Performance Shares of Geron stock traded down $0.20 during trading hours on Friday, reaching $2.

https://www.dailypolitical.com/2023/08/06/geron-nasdaqgern-issues-quarterly-earnings-results.html

#dailypolitical